Meenakshi Jain Selected Research

2-tert-butylprimaquine

8/2007

2-tert-butyl-8-quinolinamines exhibit potent blood schizontocidal antimalarial activity via inhibition of heme crystallization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meenakshi Jain Research Topics

Disease

5	Malaria 11/2022 - 10/2003
4	Neoplasms (Cancer) 01/2023 - 07/2002
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2007 - 04/2005
2	Tuberculosis (Tuberculoses) 05/2004 - 02/2002
1	Vector Borne Diseases 11/2022
1	Infections 11/2022
1	Severe Acute Respiratory Syndrome 06/2022
1	Hemolysis 08/2007
1	Cardiomegaly (Heart Hypertrophy) 04/2005
1	Diabetic Neuropathies (Diabetic Neuropathy) 04/2005
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2005
1	Carcinoma (Carcinomatosis) 04/2005
1	Papillomavirus Infections 04/2005
1	Pre-Eclampsia (Preeclampsia) 06/2004

Drug/Important Bio-Agent (IBA)

4	Chloroquine (Aralen)FDA LinkGeneric 08/2010 - 10/2003
2	AntibodiesIBA 01/2023 - 06/2004
2	DNA (Deoxyribonucleic Acid)IBA 04/2007 - 04/2005
1	Proteolysis Targeting ChimeraIBA 01/2023
1	Antimalarials (Antimalarial Agents)IBA 11/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2022
1	QuinolinesIBA 08/2010
1	quinolineIBA 08/2010
1	hemozoinIBA 08/2007
1	2-tert-butylprimaquineIBA 08/2007
1	Heme (Haem)IBA 08/2007
1	MethyltransferasesIBA 04/2007
1	Biomarkers (Surrogate Marker)IBA 04/2007
1	CalcineurinIBA 04/2005
1	oxidized low density lipoproteinIBA 06/2004
1	Antitubercular AgentsIBA 05/2004
1	Isoniazid (Ftivazide)FDA LinkGeneric 05/2004

Therapy/Procedure

2	Therapeutics 07/2002 - 02/2002
1	Drug Therapy (Chemotherapy) 11/2022